<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="08/06/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7713868" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>7713868</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_family_or_group" id="T1" lex="platelet-activating_factor">Platelet-activating factor</term> stimulates transcription of the <term sem="Protein_molecule" id="T2" lex="heparin-binding_epidermal_growth_factor-like_growth_factor">heparin-binding epidermal growth factor-like growth factor</term> in <term sem="Cell_natural" id="T3" lex="monocyte">monocytes</term>.</sentence>
<event id="E1">
<type class="Transcription" />
<theme idref="T2" />
<clue>Platelet-activating factor stimulates <clueType>transcription</clueType> <linkTheme>of</linkTheme> the heparin-binding epidermal growth factor-like growth factor in monocytes.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="T1" />
<clue>Platelet-activating factor <clueType>stimulates</clueType> transcription of the heparin-binding epidermal growth factor-like growth factor <clueLoc>in monocytes</clueLoc>.</clue>
</event>
<sentence id="S2">Correlation with an increased <term sem="Other" id="T4" lex="kappa_B_binding_activity"><term sem="DNA_domain_or_region" id="A21">kappa B</term> binding activity</term>.</sentence>
<event id="E51">
<type class="Binding" />
<theme idref="A21" />
<clue>Correlation with an increased kappa B <clueType>binding activity</clueType>.</clue>
</event>
<event id="E3">
<type class="Positive_regulation" />
<theme idref="T4" />
<clue>Correlation with an <clueType>increased</clueType> kappa B binding activity.</clue>
</event>
<event id="E4">
<type class="Correlation" />
<theme idref="E3" />
<theme idref="E2" />
<clue><clueType>Correlation</clueType> <linkTheme>with</linkTheme> an increased kappa B binding activity.</clue>
<comment>NO COREFTHEME</comment>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3">Human peripheral blood <term sem="Cell_natural" id="T5" lex="monocyte">monocytes</term> responded to stimulation of <term sem="Protein_molecule" id="T6" lex="platelet-activating_factor">platelet-activating factor</term> (<term sem="Protein_molecule" id="T7" lex="PAF">PAF</term>) with up-regulation of the <term sem="RNA_molecule" id="A1">transcript for <term sem="Protein_molecule" id="T8" lex="heparin-binding_epidermal_growth_factor-like_growth_factor">heparin-binding epidermal growth factor-like growth factor</term> (<term sem="Protein_molecule" id="T9" lex="HB-EGF">HB-EGF</term>)</term>, a <term sem="Protein_family_or_group" id="T10" lex="potent_mitogen">potent mitogen</term> for <term sem="Cell_natural" id="T11" lex="vascular_smooth_muscle_cell">vascular smooth muscle cells</term>.</sentence>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="A1" />
<cause idref="T7" />
<clue><clueLoc>Human peripheral blood monocytes</clueLoc> responded to stimulation of platelet-activating factor (PAF) with <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> the transcript for heparin-binding epidermal growth factor-like growth factor (HB-EGF), a potent mitogen for vascular smooth muscle cells.</clue>
<comment>TPS: A1</comment>
</event>
<event id="E52">
<type class="Physiological_process" />
<theme idref="T11" />
<cause idref="T9" />
<clue>Human peripheral blood monocytes responded to stimulation of platelet-activating factor (PAF) with up-regulation of the transcript for heparin-binding epidermal growth factor-like growth factor (HB-EGF), a potent <corefCause>mitogen</corefCause> <linkTheme>for</linkTheme> vascular smooth muscle cells.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S4">This function of <term sem="Protein_molecule" id="T12" lex="PAF">PAF</term> was observed at nanomolar concentrations of the ligand, starting at 30 min after stimulation.</sentence>
<sentence id="S5">The <term sem="Protein_molecule" id="T13" lex="PAF">PAF</term>-induced up-regulation of <term sem="RNA_molecule" id="T14" lex="HB-EGF_mRNA"><term sem="Protein_molecule" id="T15" lex="HB-EGF">HB-EGF</term> mRNA</term> was accompanied by an increase in <term sem="Other" id="T16" lex="kappa_B_binding_activity"><term sem="DNA_domain_or_region" id="A23">kappa B</term> binding activity</term>.</sentence>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="T14" />
<cause idref="T13" />
<clue>The PAF-<linkCause>induced</linkCause> <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> HB-EGF mRNA was accompanied by an increase in kappa B binding activity.</clue>
</event>
<event id="E53">
<type class="Binding" />
<theme idref="A23" />
<clue>The PAF-induced up-regulation of HB-EGF mRNA was accompanied by an increase in kappa B <clueType>binding activity</clueType>.</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="E53" />
<clue>The PAF-induced up-regulation of HB-EGF mRNA was accompanied by an <clueType>increase</clueType> <linkTheme>in</linkTheme> kappa B binding activity.</clue>
</event>
<event id="E8">
<type class="Correlation" />
<theme idref="E6" />
<theme idref="E7" />
<clue>The PAF-induced up-regulation of HB-EGF mRNA was <clueType>accompanied</clueType> <linkTheme>by</linkTheme> an increase in kappa B binding activity.</clue>
</event>
<sentence id="S6">These functions of <term sem="Protein_molecule" id="T17" lex="PAF">PAF</term> appeared to be mediated through the <term sem="Protein_family_or_group" id="T18" lex="cell_surface_PAF_receptor">cell surface <term sem="Protein_molecule" id="T19" lex="PAF">PAF</term> receptors</term>, as two <term sem="Organic_compound_other" id="T20" lex="PAF_receptor_antagonist"><term sem="Protein_molecule" id="T21" lex="PAF">PAF</term> receptor antagonists</term>, <term sem="Organic_compound_other" id="T22" lex="WEB_2086">WEB 2086</term> and <term sem="Organic_compound_other" id="T23" lex="L-659,989">L-659,989</term>, blocked both the up-regulation of <term sem="RNA_molecule" id="T24" lex="HB-EGF_mRNA"><term sem="Protein_molecule" id="T25" lex="HB-EGF">HB-EGF</term> mRNA</term> and <term sem="Other" id="T26" lex="kappa_B_binding_activity"><term sem="DNA_domain_or_region" id="A24">kappa B</term> binding activity</term> induced by <term sem="Protein_molecule" id="T27" lex="PAF">PAF</term>.</sentence>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="T24" />
<cause idref="T27" />
<clue>These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, blocked both the <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> HB-EGF mRNA and kappa B binding activity induced <linkCause>by</linkCause> PAF.</clue>
</event>
<event id="E54">
<type class="Binding" />
<theme idref="A24" />
<clue>These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, blocked both the up-regulation of HB-EGF mRNA and kappa B <clueType>binding activity</clueType> induced by PAF.</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="E54" />
<cause idref="T27" />
<clue>These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, blocked both the <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> HB-EGF mRNA and kappa B binding activity induced <linkCause>by</linkCause> PAF.</clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="E9" />
<cause idref="T22" />
<clue>These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, <clueType>blocked</clueType> both the up-regulation of HB-EGF mRNA and kappa B binding activity induced by PAF.</clue>
</event>
<event id="E12">
<type class="Negative_regulation" />
<theme idref="E9" />
<cause idref="T23" />
<clue>These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, <clueType>blocked</clueType> both the up-regulation of HB-EGF mRNA and kappa B binding activity induced by PAF.</clue>
</event>
<event id="E13">
<type class="Negative_regulation" />
<theme idref="E10" />
<cause idref="T22" />
<clue>These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, <clueType>blocked</clueType> both the up-regulation of HB-EGF mRNA and kappa B binding activity induced by PAF.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E10" />
<cause idref="T23" />
<clue>These functions of PAF appeared to be mediated through the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, <clueType>blocked</clueType> both the up-regulation of HB-EGF mRNA and kappa B binding activity induced by PAF.</clue>
</event>
<event uncertainty="probable" id="E15">
<type class="Positive_regulation" />
<theme idref="E6" />
<cause idref="T18" />
<clue><corefTheme>These functions of PAF</corefTheme> appeared to be <clueType>mediated</clueType> <linkCause>through</linkCause> the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, blocked both the up-regulation of HB-EGF mRNA and kappa B binding activity induced by PAF.</clue>
</event>
<event uncertainty="probable" id="E150">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="T18" />
<clue><corefTheme>These functions of PAF</corefTheme> appeared to be <clueType>mediated</clueType> <linkCause>through</linkCause> the cell surface PAF receptors, as two PAF receptor antagonists, WEB 2086 and L-659,989, blocked both the up-regulation of HB-EGF mRNA and kappa B binding activity induced by PAF.</clue>
</event>
<sentence id="S7">The antagonists, however, had no effect on <term sem="Other" id="T28" lex="phorbol_ester-induced_up-regulation"><term sem="Organic_compound_other" id="T29" lex="phorbol_ester">phorbol ester</term>-induced up-regulation</term> of <term sem="RNA_family_or_group" id="T30" lex="HB-EGF_mRNA"><term sem="Protein_molecule" id="T31" lex="HB-EGF">HB-EGF</term> mRNA</term> and <term sem="Other" id="T32" lex="kappa_B_binding_activity"><term sem="DNA_domain_or_region" id="A25">kappa B</term> binding activity</term>.</sentence>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="T30" />
<cause idref="T29" />
<clue>The antagonists, however, had no effect on phorbol ester-<linkCause>induced</linkCause> <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> HB-EGF mRNA and kappa B binding activity.</clue>
</event>
<event id="E56">
<type class="Binding" />
<theme idref="A25" />
<clue>The antagonists, however, had no effect on phorbol ester-induced up-regulation of HB-EGF mRNA and kappa B <clueType>binding activity</clueType>.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="E56" />
<cause idref="T29" />
<clue>The antagonists, however, had no effect on phorbol ester-<linkCause>induced</linkCause> <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> HB-EGF mRNA and kappa B binding activity.</clue>
</event>
<event assertion="non-exist" id="E18">
<type class="Regulation" />
<theme idref="E16" />
<cause idref="T22" />
<clue><corefCause>The antagonists</corefCause>, however, had no <clueType>effect</clueType> <linkTheme>on</linkTheme> phorbol ester-induced up-regulation of HB-EGF mRNA and kappa B binding activity.</clue>
</event>
<event assertion="non-exist" id="E19">
<type class="Regulation" />
<theme idref="E16" />
<cause idref="T23" />
<clue><corefCause>The antagonists</corefCause>, however, had no <clueType>effect</clueType> <linkTheme>on</linkTheme> phorbol ester-induced up-regulation of HB-EGF mRNA and kappa B binding activity.</clue>
</event>
<event assertion="non-exist" id="E20">
<type class="Regulation" />
<theme idref="E17" />
<cause idref="T22" />
<clue><corefCause>The antagonists</corefCause>, however, had no <clueType>effect</clueType> <linkTheme>on</linkTheme> phorbol ester-induced up-regulation of HB-EGF mRNA and kappa B binding activity.</clue>
</event>
<event assertion="non-exist" id="E21">
<type class="Regulation" />
<theme idref="E17" />
<cause idref="T23" />
<clue><corefCause>The antagonists</corefCause>, however, had no <clueType>effect</clueType> <linkTheme>on</linkTheme> phorbol ester-induced up-regulation of HB-EGF mRNA and kappa B binding activity.</clue>
</event>
<sentence id="S8">Pretreatment of <term sem="Cell_natural" id="T33" lex="monocyte">monocytes</term> with <term sem="Organic_compound_other" id="A2">pertussis toxin</term> inhibited these functions of <term sem="Protein_molecule" id="T34" lex="PAF">PAF</term>, whereas <term sem="Organic_compound_other" id="T35" lex="cholera_toxin">cholera toxin</term> had no inhibitory effect.</sentence>
<event id="E57">
<type class="Artificial_process" />
<theme idref="T33" />
<theme idref="A2" />
<clue><clueType>Pretreatment</clueType> <linkTheme>of</linkTheme> monocytes <linkTheme>with</linkTheme> pertussis toxin inhibited these functions of PAF, whereas cholera toxin had no inhibitory effect.</clue>
</event>
<event id="E58">
<type class="Artificial_process" />
<theme idref="T35" />
<theme idref="A2" />
<clue><clueType>Pretreatment</clueType> <linkTheme>of</linkTheme> monocytes <linkTheme>with</linkTheme> pertussis toxin inhibited these functions of PAF, whereas cholera toxin had no inhibitory effect.</clue>
</event>
<event id="E120">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="E57" />
<clue>Pretreatment of monocytes with pertussis toxin <clueType>inhibited</clueType> <corefTheme>these functions of PAF</corefTheme>, whereas cholera toxin had no inhibitory effect.</clue>
</event>
<event id="E121">
<type class="Negative_regulation" />
<theme idref="E7" />
<cause idref="E57" />
<clue>Pretreatment of monocytes with pertussis toxin <clueType>inhibited</clueType> <corefTheme>these functions of PAF</corefTheme>, whereas cholera toxin had no inhibitory effect.</clue>
</event>
<event assertion="non-exist" id="E122">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="E58" />
<clue>Pretreatment of monocytes with pertussis toxin inhibited <corefTheme>these functions of PAF</corefTheme>, whereas cholera toxin had no <clueType>inhibitory effect</clueType>.</clue>
</event>
<event assertion="non-exist" id="E123">
<type class="Negative_regulation" />
<theme idref="E7" />
<cause idref="E58" />
<clue>Pretreatment of monocytes with pertussis toxin inhibited <corefTheme>these functions of PAF</corefTheme>, whereas cholera toxin had no <clueType>inhibitory effect</clueType>.</clue>
</event>
<sentence id="S9"><term sem="Organic_compound_other" id="T36" lex="pyrrolidine_dithiocarbamate">Pyrrolidine dithiocarbamate</term>, an inhibitor for <term sem="Other" id="T37" lex="NF-kappa_B_activation"><term sem="Protein_molecule" id="T38" lex="NF-kappa_B">NF-kappa B</term> activation</term>, markedly reduced <term sem="Other" id="T39" lex="PAF-stimulated_kappa_B_binding_activity"><term sem="Protein_molecule" id="T40" lex="PAF">PAF</term>-stimulated <term sem="Other" id="T41" lex="kappa_B_binding_activity"><term sem="DNA_domain_or_region" id="A26">kappa B</term> binding activity</term></term> as well as up-regulation of <term sem="RNA_molecule" id="T42" lex="HB-EGF_mRNA"><term sem="Protein_molecule" id="T43" lex="HB-EGF">HB-EGF</term> mRNA</term>.</sentence>
<event id="E60">
<type class="Positive_regulation" />
<theme idref="T38" />
<clue>Pyrrolidine dithiocarbamate, an inhibitor for NF-kappa B <clueType>activation</clueType>, markedly reduced PAF-stimulated kappa B binding activity as well as up-regulation of HB-EGF mRNA.</clue>
</event>
<event id="E61">
<type class="Negative_regulation" />
<theme idref="E60" />
<cause idref="T36" />
<clue>Pyrrolidine dithiocarbamate, an <clueType>inhibitor</clueType> <linkTheme>for</linkTheme> NF-kappa B activation, markedly reduced PAF-stimulated kappa B binding activity as well as up-regulation of HB-EGF mRNA.</clue>
</event>
<event id="E59">
<type class="Binding" />
<theme idref="A26" />
<clue>Pyrrolidine dithiocarbamate, an inhibitor for NF-kappa B activation, markedly reduced PAF-stimulated kappa B <clueType>binding activity</clueType> as well as up-regulation of HB-EGF mRNA.</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="E59" />
<cause idref="T40" />
<clue>Pyrrolidine dithiocarbamate, an inhibitor for NF-kappa B activation, markedly reduced PAF-<clueType>stimulated</clueType> kappa B binding activity as well as up-regulation of HB-EGF mRNA.</clue>
</event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="T42" />
<cause idref="T40" />
<clue>Pyrrolidine dithiocarbamate, an inhibitor for NF-kappa B activation, markedly reduced PAF-<linkCause>stimulated</linkCause> kappa B binding activity as well as <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> HB-EGF mRNA.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="T36" />
<clue>Pyrrolidine dithiocarbamate, an inhibitor for NF-kappa B activation, markedly <clueType>reduced</clueType> PAF-stimulated kappa B binding activity as well as up-regulation of HB-EGF mRNA.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E25" />
<cause idref="T36" />
<clue>Pyrrolidine dithiocarbamate, an inhibitor for NF-kappa B activation, markedly <clueType>reduced</clueType> PAF-stimulated kappa B binding activity as well as up-regulation of HB-EGF mRNA.</clue>
</event>
<sentence id="S10">These results suggest a potential role of <term sem="Protein_molecule" id="T44" lex="PAF"><term sem="Protein_molecule" id="T45" lex="PAF">PAF</term></term> in <term sem="Other" id="T46" lex="HB-EGF_expression"><term sem="Protein_family_or_group" id="T47" lex="HB-EGF"><term sem="Protein_molecule" id="T48" lex="HB-EGF">HB-EGF</term></term> expression</term> and provide evidence that this stimulation may occur through increased <term sem="Other" id="T49" lex="kappa_B_binding_activity"><term sem="Other" id="T50" lex="kappa_B_binding_activity"><term sem="DNA_domain_or_region" id="A27">kappa B</term> binding activity</term></term>.</sentence>
<event id="E28">
<type class="Gene_expression" />
<theme idref="T48" />
<clue>These results suggest a potential role of PAF in HB-EGF <clueType>expression</clueType> and provide evidence that this stimulation may occur through increased kappa B binding activity.</clue>
</event>
<event uncertainty="probable" id="E29">
<type class="Positive_regulation" />
<theme idref="E28" />
<cause idref="T45" />
<clue>These results suggest a <clueType>potential role</clueType> <linkCause>of</linkCause> PAF <linkTheme>in</linkTheme> HB-EGF expression and provide evidence that this stimulation may occur through increased kappa B binding activity.</clue>
</event>
<event id="E62">
<type class="Binding" />
<theme idref="A27" />
<clue>These results suggest a potential role of PAF in HB-EGF expression and provide evidence that this stimulation may occur through increased kappa B <clueType>binding activity</clueType>.</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="E62" />
<clue>These results suggest a potential role of PAF in HB-EGF expression and provide evidence that this stimulation may occur through <clueType>increased</clueType> kappa B binding activity.</clue>
</event>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="E29" />
<cause idref="E30" />
<clue>These results suggest a potential role of PAF in HB-EGF expression and provide evidence that <corefTheme>this stimulation</corefTheme> may <clueType>occur</clueType> <linkCause>through</linkCause> increased kappa B binding activity.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
